TRK fusion-positive lung cancers

January 10, 2022 00:21:28
TRK fusion-positive lung cancers
COR2ED Medical Education
TRK fusion-positive lung cancers

Jan 10 2022 | 00:21:28

/

Show Notes

In this medical education podcast, NTRK CONNECT members Assoc. Prof. Caterina Marchiò (University of Turin, Italy) and Prof. Christian Rolfo (Center of Thoracic Oncology Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, New York, USA) provide pathologist and medical oncologist perspectives about the detection and treatment of TRK fusion-positive lung cancers.

They discuss a number of techniques and strategies to identify this rare fusion in lung cancer patients, before going on to summarise the robust efficacy and safety data for both entrectinib and larotrectinib. Prof. Rolfo briefly covers second-generation therapies in clinical development and describes how liquid biopsy is emerging as a new technique not only to identify but also monitor patients. They conclude by stressing the importance of the collaboration and communication between pathologists and oncologists to test for and identify TRK fusion-positive lung cancer patients.

Other Episodes

Episode 2

May 12, 2021 00:21:48
Episode Cover

Radiopharmaceuticals in prostate cancer - PSMA Theranostics episode 2

Dr. Tanya Dorff (City of Hope Comprehensive Cancer Center, Los Angeles, USA) and Dr. Phillip Koo (Banner MD Anderson Cancer Center, Arizona, USA) discuss...

Listen

Episode 1

September 01, 2022 00:27:14
Episode Cover

Clinical Implications: updated Bone Sarcoma guidelines

COR2ED Medical Education: In this SARCOMA CONNECT Guidelines Podcast, two SARCOMA CONNECT Experts, Prof. Robert Maki and Prof. Silvia Stacchiotti, discuss recent updates in...

Listen

Episode 1

January 16, 2023 00:19:18
Episode Cover

Gynaecological considerations in Women with Bleeding Disorders

COR2ED Medical Education: In this podcast, Dr Sarah O’Brien and Dr Homa Ahmadzia discuss gynaecological considerations in women and girls who have an underlying...

Listen